Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0266966
Abstract: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poor prognosis. Emerging evidence suggests that epigenetic alterations play a crucial role in HCC, suggesting epigenetic inhibition as a promising therapeutic approach. Indeed, the… read more here.
Keywords: transcriptome profiling; treated hepg2; inhibitor treated; comprehensive transcriptome ... See more keywords